Drug Type Antibody oligonucleotide conjugates |
Synonyms- |
Target |
Mechanism TRIM63 inhibitors(tripartite motif containing 63 inhibitors), TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Atrophy | Discovery | US | - |